Chimeric Anti-GPC3 sFv-CD3ε Receptor-Modified T Cells with IL7 Co-Expression for the Treatment of Solid Tumors" Molecular Therapy — Oncolytics

08.04.22

Chimeric Anti-GPC3 sFv-CD3ε Receptor-Modified T Cells with IL7 Co-Expression for the Treatment of Solid Tumors" Molecular Therapy — Oncolytics

by ASTCT Science Highlights

Long-Term Patient-Reported Neurocognitive Outcomes in Adult Survivors of Hematopoietic Cell Transplant

08.02.22

Long-Term Patient-Reported Neurocognitive Outcomes in Adult Survivors of Hematopoietic Cell Transplant

by ASTCT Science Highlights

Prospective External Validation of Biomarkers to Predict Acute Graft-Versus Host Disease Severity

07.21.22

Prospective External Validation of Biomarkers to Predict Acute Graft-Versus Host Disease Severity

by ASTCT Science Highlights

$Comparative Effectiveness of ZUMA-5 (Axi-Cel) vs SCHOLAR-5 External Control in Relapsed/Refractory Follicular Lymphoma$

07.19.22

Comparative Effectiveness of ZUMA-5 (Axi-Cel) vs SCHOLAR-5 External Control in Relapsed/Refractory Follicular Lymphoma

by ASTCT Science Highlights

Dual-Specific CAR T Cell Expansion Improves Efficacy Against Solid Tumors in Mice

07.07.22

Dual-Specific CAR T Cell Expansion Improves Efficacy Against Solid Tumors in Mice

by ASTCT Science Highlights

Phenotypic Escape in CD19 -Directed Therapies

07.05.22

Phenotypic Escape in CD19 -Directed Therapies

by ASTCT Science Highlights

Transplant Outcomes in Adults with HLH

06.30.22

Transplant Outcomes in Adults with HLH

by ASTCT Science Highlights

Respiratory Viruses in Transplant Candidates

06.28.22

Respiratory Viruses in Transplant Candidates

by ASTCT Science Highlights

The 2022 ASTCT Tandem Meetings’ Spotlight Session on Delivering Culturally Sensitive Care: Conversations Between Patients and Their Providers

06.15.22

The 2022 ASTCT Tandem Meetings’ Spotlight Session on Delivering Culturally Sensitive Care: Conversations Between Patients and Their Providers

by Linda J. Burns, MD

Theme picker

Thank you to our sponsors

Amgen

pharmacyclics